相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Abdus Samad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
Maryam Enayatkhani et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Targeting human TLRs to combat COVID-19: A solution?
Ritwik Patra et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
Mahesh Chandra Patra et al.
SEMINARS IN CANCER BIOLOGY (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation
Qian Qiu et al.
EXPERIMENTAL CELL RESEARCH (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
COVID-19 and the Heart
Akbarshakh Akhmerov et al.
CIRCULATION RESEARCH (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
Rensong Ye et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019
Lin Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
Han Zhu et al.
CURRENT CARDIOLOGY REPORTS (2020)
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
Harald Murck
FRONTIERS IN IMMUNOLOGY (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19
Jiewen Fu et al.
MOLECULAR BIOLOGY REPORTS (2020)
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf Andersson et al.
MOLECULAR MEDICINE (2020)
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach
M. Shaminur Rahman et al.
PEERJ (2020)
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
Valentina O. Puntmann et al.
JAMA CARDIOLOGY (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach
Noor Rahman et al.
VACCINES (2020)
Alveolar lipids in pulmonary disease. A review
Christina W. Agudelo et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Clinical characteristics of 82 cases of death from COVID-19
Bicheng Zhang et al.
PLOS ONE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
A candidate multi-epitope vaccine against SARS-CoV-2
Tamalika Kar et al.
SCIENTIFIC REPORTS (2020)
A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption
Ahmed E. Khodir et al.
LIFE SCIENCES (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
Kyung Mok Sohn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
MYOCARDITIS IN COVID-19 PATIENTS CONFIRMED BY IMMUNOHISTOCHEMISTRY
E. A. Kogan et al.
KARDIOLOGIYA (2020)
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Phospholipid regulation of innate immunity and respiratory viral infection
Dennis R. Voelker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice
Rika Kitazume-Taneike et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Platelet TLR4 at the crossroads of thrombosis and the innate immune response
Mirta Schattner
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Angiotensin-(1-7) and Vascular Function: The Clinical Context
Rhian M. Touyz et al.
HYPERTENSION (2018)
Effects of the TLR4/Myd88/NF-kappa B Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury
Qiang Su et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats
Eman Said et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model
Ruhui Yang et al.
ATHEROSCLEROSIS (2018)
Toll-like receptor 4 in acute viral infection: Too much of a good thing
Judith Olejnik et al.
PLOS PATHOGENS (2018)
TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung
Swati Bhattacharyya et al.
JCI INSIGHT (2018)
Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future
Smeeta Sardesai et al.
PEDIATRIC RESEARCH (2017)
MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1 beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line
Man Luo et al.
MOLECULAR IMMUNOLOGY (2017)
Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use
Huijie Jia et al.
MOLECULAR MEDICINE REPORTS (2017)
The interplay between Angiotensin II, TLR4 and hypertension
Vinicia Campana Biancardi et al.
PHARMACOLOGICAL RESEARCH (2017)
Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection
Mathieu Iampietro et al.
PLOS PATHOGENS (2017)
Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program
Paula J. McKeown-Longo et al.
ADVANCES IN WOUND CARE (2017)
Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma
Swati Bhattacharyya et al.
ADVANCES IN WOUND CARE (2017)
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Nikolay N. Kuzmich et al.
VACCINES (2017)
Mechanisms of type I interferon action and its role in infections and diseases transmission in mammals
Paulina Niedzwiedzka-Rystwej et al.
ACTA BIOCHIMICA POLONICA (2017)
Pulmonary Surfactant and Bacterial Lipopolysaccharide: The Interaction and its Functional Consequences
M. Kolomaznik et al.
PHYSIOLOGICAL RESEARCH (2017)
Heart in sepsis. Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy
L. Martin et al.
ANAESTHESIST (2017)
Early innate immune responses to bacterial LPS
Charles V. Rosadini et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review
Suprabhat Mukherjee et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Sally A. Huber
CURRENT PHARMACEUTICAL DESIGN (2016)
Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)
Neil A. Turner
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
Monica Molteni et al.
MEDIATORS OF INFLAMMATION (2016)
Novel strategies for targeting innate immune responses to influenza
K. A. Shirey et al.
MUCOSAL IMMUNOLOGY (2016)
Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases
B. Garcia Bueno et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Corticosteroids Mechanisms of Action in Health and Disease
Sivapriya Ramamoorthy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
The emerging role of Toll-like receptor 4 in myocardial inflammation
Y. Yang et al.
CELL DEATH & DISEASE (2016)
TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism
Xingying He et al.
SCIENTIFIC REPORTS (2016)
HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats
Yu Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice
X. X. Li et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Yu Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1
Yun-peng Luo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Protein Kinase Cε-Calcineurin Cosignaling Downstream of Toll-Like Receptor 4 Downregulates Fibrosis and Induces Wound Healing Gene Expression in Cardiac Myofibroblasts
Rui F. D. S. Mesquita et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Pathogenesis of influenza-induced acute respiratory distress syndrome
Kirsty R. Short et al.
LANCET INFECTIOUS DISEASES (2014)
Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress
Richard A. Polin et al.
PEDIATRICS (2014)
Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation
Wenbo Zhang et al.
PLOS ONE (2014)
Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome
Tiffany Horng
TRENDS IN IMMUNOLOGY (2014)
Immunomodulatory activity of interferon-beta
Lloyd H. Kasper et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey et al.
NATURE (2013)
Differential Response of Primary Alveolar Type I and Type II Cells to LPS Stimulation
Mandi H. Wong et al.
PLOS ONE (2013)
Make Yourself at Home: Viral Hijacking of the PI3K/Akt Signaling Pathway
Nora Diehl et al.
VIRUSES-BASEL (2013)
Diverse Functions of Pulmonary Collectins in Host Defense of the Lung
Shigeru Ariki et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Diagnosis and Treatment of Viral Myocarditis
Jason C. Schultz et al.
MAYO CLINIC PROCEEDINGS (2012)
Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide3-Kinase-Akt Pathway
Zhengyu He et al.
PLOS ONE (2012)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Ivan Zanoni et al.
CELL (2011)
Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
A. Kaparianos et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy
Heidi Ehrentraut et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
TRIF Is a Critical Survival Factor in Viral Cardiomyopathy
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2011)
Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction
Gemma Vilahur et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway
Leonid Tarassishin et al.
JOURNAL OF NEUROINFLAMMATION (2011)
TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
Naoko Matsunaga et al.
MOLECULAR PHARMACOLOGY (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Psoriasis and extra domain A fibronectin loops
J. P. McFadden et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts
J. P. Burke et al.
BRITISH JOURNAL OF SURGERY (2010)
Pulmonary Surfactant: An Immunological Perspective
Zissis C. Chroneos et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2010)
Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury
Hiroyuki Seki et al.
INFLAMMATION RESEARCH (2010)
Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains
Wondwossen Abate et al.
JOURNAL OF LIPID RESEARCH (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2
Koji Kuronuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion
Ning Zou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
Leo Timmers et al.
CIRCULATION RESEARCH (2008)
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
Jonathan C. Kagan et al.
NATURE IMMUNOLOGY (2008)
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Timothy Sheahan et al.
PLOS PATHOGENS (2008)
Mechanisms of disease: Toll-like receptors in cardiovascular disease
Stefan Frantz et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury
Akira Shimamoto et al.
CIRCULATION (2006)
Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart
E. Ann Tallant et al.
FUTURE CARDIOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Cellular and molecular mechanisms underlying LPS-associated myocyte impairment
SA Tavener et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
TZ Ha et al.
CARDIOVASCULAR RESEARCH (2005)
Respiratory epithelial cells require Toll-like receptor 4 for induction of human b-defensin 2 by lipopolysaccharide
R MacRedmond et al.
RESPIRATORY RESEARCH (2005)
Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production
K Fuse et al.
CIRCULATION (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Tissue-specific mRNA expression profiles of human toll-like receptors and related genes
M Nishimura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Reading the viral signature by toll-like receptors and other pattern recognition receptors
TH Mogensen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung
KC Chow et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
SS Diebold et al.
SCIENCE (2004)
Modulating Toll-like receptor mediated signaling by (1→3)-β-D-glucan rapidly induces cardioprotection
CF Li et al.
CARDIOVASCULAR RESEARCH (2004)
Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices
EJ Birks et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Expression of functional toll-like receptor-2 and-4 on alveolar epithelial cells
L Armstrong et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus
D Burzyn et al.
JOURNAL OF VIROLOGY (2004)
Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin
MM Monick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Toll-like receptors in cardiovascular diseases
D de Kleijn et al.
CARDIOVASCULAR RESEARCH (2003)
Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein
YM Zhang et al.
JOURNAL OF VIROLOGY (2003)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
IL-12 receptor β1 and Toll-like receptor 4 increase IL-1β- and IL-18-associated myocarditis and Coxsackievirus replication
D Fairweather et al.
JOURNAL OF IMMUNOLOGY (2003)
Respiratory syncytial virus-induced activation of nuclear factor-κB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways
HA Haeberle et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus
TA Martino et al.
VIROLOGY (2000)
Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs
M Thompson et al.
PEDIATRIC RESEARCH (2000)
分享论文
